Evidence map›Paper›PMID 35493915›Full record

ArticleRSC advances2020

Chemical fingerprinting and quantitative monitoring of the doping drugs bambuterol and terbutaline in human urine samples using ATR-FTIR coupled with a PLSR chemometric tool.

Faisal K Algethami, Sherif M Eid, Khadiga M Kelani, Mohamed R Elghobashy, Mohamed K Abd El-Rahman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Faisal K AlgethamiChemistry Department, Faculty of Science, Imam Mohammed ibn Saud Islamic University Riyadh Saudi Arabia.
Sherif M EidAnalytical Chemistry Department, Faculty of Pharmacy, October 6 University 6 October City Giza Egypt Sheriefmohammed@o6u.edu.eg Sherief055@icloud.com +201111609539.ORCID https://orcid.org/0000-0003-0899-7792
Khadiga M KelaniAnalytical Chemistry Department, Faculty of Pharmacy, Cairo University El-Kasr El-Aini Street ET-11562 Cairo Egypt.
Mohamed R ElghobashyAnalytical Chemistry Department, Faculty of Pharmacy, October 6 University 6 October City Giza Egypt Sheriefmohammed@o6u.edu.eg Sherief055@icloud.com +201111609539.
Mohamed K Abd El-RahmanAnalytical Chemistry Department, Faculty of Pharmacy, Cairo University El-Kasr El-Aini Street ET-11562 Cairo Egypt.
Cairo University · EGImam Mohammad ibn Saud Islamic University · SAOctober 6 University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of performance-enhancing drugs is prohibited in sports competitions according to the World Anti-Doping Agency (WADA) regulations. Here, ATR-FTIR spectroscopy coupled with a partial least squares regression (PLSR) chemometric tool was used for the detection of the misuse of such substances. Bambuterol and its metabolite terbutaline have been included in the list of prohibited doping agents. Therefore, we used bambuterol and terbutaline as models for the accurate and simultaneous qualitative and quantitative analysis of bambuterol and terbutaline in human urine samples. The method was straightforward and once the urine samples were collected, they could be directly applied to the surface of the ZnSe prism (ATR unit) to get the results within one minute. A calibration set with a partial factorial design was used to develop the PLSR model that could be used to predict the concentration of unknown samples containing the two drugs. The developed method was carefully validated and successfully applied to the urine sample analysis of human volunteers. The drugs were quantified at nanogram level concentrations. A side-by-side comparison of the proposed method with the routine GC-MS method was performed to demonstrate the challenges and opportunities of each method.

Identifiers

PMID35493915
PMCPMC9049731
OpenAlexW3005833760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.